Skip to content

Clinical Observation on the Therapeutic Efficacy of Electrical Nerve Stimulation Wacth in Treating Mild to Moderate Insomnia

Clinical Observation on the Efficacy of a Second-Generation Portable Wearable Physiotherapy Watch in the Treatment of Mild to Moderate Insomnia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001342
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Electroacupuncture Group:Electroacupuncture
Electrical Nerve Stimulation Wacth Group:Watch-Based Electrical Nerve Stimulation

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for short-term insomnia as specified in the Guidelines for the diagnosis and treatment of insomnia disorder (2025) by the Chinese Sleep Research Society, and meet the TCM clinical guidelines of insomnia research group (WHO/WPO) (2016); (2) Aged between 18 and 65 years, with no gender restriction; (3) Have a total Pittsburgh Sleep Quality Index (PSQI) score ranging from 6 to 15; (4) Have not used any sedative-hypnotic or psychotropic medications within the four weeks prior to the trial; (5) Voluntarily participate in this study and sign the informed consent form; (6) Have not participated in any other research projects within the past month that could potentially affect the outcomes of this study. Patients meeting all of the above 6 criteria are eligible for inclusion in this study.

Exclusion criteria

Exclusion criteria: (1) Those who have secondary insomnia caused by organic diseases; those who have sleep-disordered breathing, circadian rhythm sleep disorders, or parasomnias; those who have a history of sleep apnea; (2) Those who have severe mental illnesses such as depression, anxiety disorders, or schizophrenia; those who have insomnia caused by neurological diseases (e.g., stroke, Parkinson's disease) or by mental disorders such as anxiety and depression; (3) Those who have insomnia caused by systemic diseases (e.g., pain, fever, cough, surgery) or external environmental interference factors; (4) Those who have life-threatening conditions such as cardiovascular or cerebrovascular diseases, hepatorenal insufficiency, or hematopoietic system disorders; (5) Those who have progressive malignant tumors or other severe consumptive diseases that are prone to infection and bleeding; (6) Those who are addicted to drugs, alcohol, or tobacco; those who are pregnant or breastfeeding; (7) Those who have severe skin infections at acupoint sites; those who have a fear of acupuncture. Patients who meet any of the above criteria will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
PSQI;

Secondary

MeasureTime frame
Electromyographic signal;

Countries

China

Contacts

Public ContactTingting Ma

Hospital of Chengdu University of Traditional Chinese Medicine

6080934@qq.com+86 13550086707

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026